PRECLINICAL STUDY: Ghrelin stimulates locomotor activity and accumbal dopamine‐overflow via central cholinergic systems in mice: implications for its involvement in brain reward

Addiction Biology - Tập 11 Số 1 - Trang 45-54 - 2006
Elisabet Jerlhag1, Emil Egecioglu2, Suzanne L. Dickson2, Malin Andersson1, Lennart Svensson1, Jörgen A. Engel1
1Institute of Pharmacology and Physiology, Department of Pharmacology, Göteborg University, Sweden and
2Institute of Pharmacology and Physiology, Division of Endocrinology, Göteborg University, Sweden

Tóm tắt

ABSTRACT

It is becoming increasingly apparent that there is a degree of neurochemical overlap between the reward systems and those regulating energy balance. We therefore investigated whether ghrelin, a stomach‐derived and centrally derived orexigenic peptide, might act on the reward systems. Central ghrelin administration (1 µg/µL, to the third ventricle) induced an acute increase in locomotor activity as well as dopamine‐overflow in the nucleus accumbens, suggesting that ghrelin can activate the mesoaccumbal dopamine system originating in the ventral tegmental area, a system associated with reward and motivated behaviour. The cholinergic afferents to the ventral tegmental area have been implicated in natural reward and in regulating mesoaccumbal dopamine neurons. The possibility that nicotinic receptors are involved in mediating the stimulatory and dopamine‐enhancing effects of ghrelin is supported by the findings that peripheral injection of the unselective nicotinic antagonist mecamylamine (2.0 mg/kg) blocked these ghrelin‐induced effects. Tentatively, ghrelin may, via activation of the acetylcholine–dopamine reward link, increase the incentive values of signals associated with motivated behaviours of importance for survival such as feeding behaviour. It will be important to discover whether this has therapeutic implications for compulsive addictive behaviours, such as eating behaviour disorders and drug dependence.

Từ khóa


Tài liệu tham khảo

10.1016/S0165-0173(98)00019-8

10.1016/j.bbrc.2004.11.116

10.1097/01.ALC.0000145790.60216.C8

10.1016/0014-2999(93)90434-J

10.1016/S0014-2999(97)01220-X

10.1016/0361-9230(92)90023-Q

10.1016/S0014-2999(02)02552-9

Butcher LL, 2003, The Rat Nervous System, 1257

10.1016/S0896-6273(03)00063-1

10.1038/nm0702-643

10.2337/diabetes.50.8.1714

10.1037/0735-7044.106.1.181

Engel JA, 1977, Recent Advances in the Study of Alcoholism (Excerpta Medica International Congress Series 407), 16

Engel JA, 1977, Cathecolamines and Behavior, 1

10.1097/00002826-199201001-00035

10.1016/S0014-2999(98)00602-5

Esch T, 2004, The neurobiology of pleasure, reward processes, addiction and their health implications, Neuroendocrinol Lett, 25, 235

10.1097/00004583-200207000-00018

Franklin KBJ, 1996, The Mouse Brain in Stereotaxic Coordinates

10.1002/(SICI)1096-9861(19990726)410:2<197::AID-CNE3>3.0.CO;2-D

10.1016/S0169-328X(97)00071-5

10.1515/REVNEURO.2002.13.1.85

10.1210/endo.142.10.8490

10.1126/science.273.5277.974

10.1111/j.1369-1600.2004.tb00534.x

10.1093/alcalc/agh108

10.1523/JNEUROSCI.21-16-j0002.2001

10.1038/45230

10.1111/j.1749-6632.1992.tb25966.x

10.1530/eje.0.151S067

10.1016/j.ejphar.2003.09.047

10.1006/bbrc.2000.4065

10.1016/S0306-4522(99)00607-7

LarssonA(2004)On cholinergic mechanisms involved in ethanol reinforcement—a behavioural and neurochemical study in rodents.Thesis.ISBN: 91‐628‐6202‐2. öIntellecta Docusys Göteborg Sweden.

10.1093/alcalc/agh180

10.1016/j.neubiorev.2003.11.010

10.1016/S0741-8329(02)00244-6

10.1097/01.ALC.0000148099.12344.C8

10.1016/0091-3057(95)00187-5

10.1530/eje.0.149R001

10.1038/35051587

10.1530/eje.0.1450669

10.1126/science.7624776

10.1001/archpsyc.60.8.828

10.1016/S0741-8329(04)00097-7

10.1016/S0006-8993(98)00315-1

10.1016/S0091-3057(99)00218-X

10.1016/j.neulet.2004.10.084

10.1016/0165-0173(93)90013-P

10.1016/S0196-9781(01)00633-7

10.1007/BF00228127

10.1016/S0306-4530(02)00066-5

10.1210/en.2004-0529

10.1016/j.npep.2003.10.002

10.1097/01.ALC.0000113777.87190.9C

10.1038/35038090

10.2337/diabetes.50.4.707

10.1038/nrn1539

10.1002/syn.10075

10.1002/eat.10118

10.1300/J069v23n03_04

10.1016/0014-2999(93)90075-S

10.1002/(SICI)1098-108X(199805)23:4<433::AID-EAT11>3.0.CO;2-X

10.1016/0163-7258(87)90108-2

10.1016/S0896-6273(02)00965-0

10.1037/0033-295X.94.4.469

10.1146/annurev.ps.40.020189.001203

10.1016/0301-0082(91)90006-M

10.1037/0735-7044.107.6.1077